A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS
TAKE II
1 other identifier
interventional
60
1 country
1
Brief Summary
We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 diabetes-mellitus
Started Feb 2003
Longer than P75 for phase_4 diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedJanuary 25, 2016
January 1, 2016
3.8 years
September 14, 2005
January 22, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
glucose
4 months
Secondary Outcomes (2)
Change in lipids
4 months
blood pressure
4 months
Study Arms (3)
A
EXPERIMENTALACTOS plus standard diet
B
EXPERIMENTALActos plus structured diet
C
EXPERIMENTALMetformin plus standard diet
Interventions
Eligibility Criteria
You may qualify if:
- Men and women age 35 to 75 who have type 2 diabetes mellitus
You may not qualify if:
- Individuals with co-existing other diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Center
Baton Rouge, Louisiana, 70808, United States
Related Publications (2)
Martin CK, Gupta AK, Smith SR, Greenway FL, Han H, Bray GA. Effect of pioglitazone on energy intake and ghrelin in diabetic patients. Diabetes Care. 2010 Apr;33(4):742-4. doi: 10.2337/dc09-1600. Epub 2010 Jan 12.
PMID: 20067964DERIVEDGupta AK, Smith SR, Greenway FL, Bray GA. Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes Obes Metab. 2009 Apr;11(4):330-7. doi: 10.1111/j.1463-1326.2008.00965.x.
PMID: 19267711DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George A Bray, MD
Pennington Center
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Adjunct
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 22, 2005
Study Start
February 1, 2003
Primary Completion
December 1, 2006
Study Completion
December 1, 2006
Last Updated
January 25, 2016
Record last verified: 2016-01